RxDoctor Payments Data

Saqib Rehman, MD

Orthopaedic Surgery · Philadelphia, PANPI 1407844376

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (38.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Globus Medical at 56.9% of the total. Reporting peaked in 2023 at $17,288 and has fallen 57.3% since, to $7,383 in 2025.

$53,911in general payments, 2019–2025

Across 77 payments — averaging $700.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$31K
  • Synthes GmbH$13K
  • Synthes USA Products LLC$6K
  • Medical Device Business Services, Inc.$2K
  • Stryker$634
  • Liberty Surgical Inc.$517
  • plus $777 from 3 others
$83,300in research payments, 2019–2025

Across 10 payments — averaging $8330.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$83K

What the payments were for

  • Royalty or licence$20,75739%
  • Consulting fees$12,60823%
  • Speaking & faculty fees$12,00022%
  • Travel & lodging$6,05611%
  • Food & beverage$1,9744%
  • Education$5171%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical31$30,684
Synthes GmbH17$12,863
Synthes USA Products LLC8$6,002
Medical Device Business Services, Inc.12$2,435
Stryker5$634
Liberty Surgical Inc.1$517
Orthoxel Designated Activity Company1$500
Curvafix, Inc.1$144
Vapotherm Inc1$132

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,911 in reported general payments places this provider in the 85th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$40,347
Medicare patients
80
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam12$38
Oxycodone Hcl20$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →